JP2020530494A5 - - Google Patents

Info

Publication number

JP2020530494A5

JP2020530494A5 JP2020530424A JP2020530424A JP2020530494A5 JP 2020530494 A5 JP2020530494 A5 JP 2020530494A5 JP 2020530424 A JP2020530424 A JP 2020530424A JP 2020530424 A JP2020530424 A JP 2020530424A JP 2020530494 A5 JP2020530494 A5 JP 2020530494A5

Authority

JP

Japan

Prior art keywords

pharmaceutical composition

composition according

bacterial

therapy

rrna sequence

Prior art date

2018-08-07

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 230000001580 bacterial effect Effects 0.000 claims description 203
• 239000008194 pharmaceutical composition Substances 0.000 claims description 115
• 108020004465 16S ribosomal RNA Proteins 0.000 claims description 94
• 238000011319 anticancer therapy Methods 0.000 claims description 21
• 206010040047 Sepsis Diseases 0.000 claims description 14
• 208000037815 bloodstream infection Diseases 0.000 claims description 14
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 10
• 238000004519 manufacturing process Methods 0.000 claims description 10
• 150000004666 short chain fatty acids Chemical group 0.000 claims description 10
• 238000002512 chemotherapy Methods 0.000 claims description 9
• 210000005027 intestinal barrier Anatomy 0.000 claims description 8
• 230000007358 intestinal barrier function Effects 0.000 claims description 8
• 238000002626 targeted therapy Methods 0.000 claims description 8
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 6
• 230000000968 intestinal effect Effects 0.000 claims description 6
• 238000002560 therapeutic procedure Methods 0.000 claims description 5
• 206010009900 Colitis ulcerative Diseases 0.000 claims description 4
• 208000011231 Crohn disease Diseases 0.000 claims description 4
• 201000006704 Ulcerative Colitis Diseases 0.000 claims description 4
• 230000005856 abnormality Effects 0.000 claims description 4
• 201000010099 disease Diseases 0.000 claims description 4
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
• 230000002550 fecal effect Effects 0.000 claims description 4
• 238000001959 radiotherapy Methods 0.000 claims description 4
• 230000003248 secreting effect Effects 0.000 claims description 4
• 238000001356 surgical procedure Methods 0.000 claims description 4
• 238000009169 immunotherapy Methods 0.000 claims description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
• 208000027496 Behcet disease Diseases 0.000 claims 2
• 206010009895 Colitis ischaemic Diseases 0.000 claims 2
• 206010056979 Colitis microscopic Diseases 0.000 claims 2
• 206010058838 Enterocolitis infectious Diseases 0.000 claims 2
• 208000002389 Pouchitis Diseases 0.000 claims 2
• 206010009887 colitis Diseases 0.000 claims 2
• 208000008609 collagenous colitis Diseases 0.000 claims 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
• 201000008243 diversion colitis Diseases 0.000 claims 2
• 208000027139 infectious colitis Diseases 0.000 claims 2
• 201000008222 ischemic colitis Diseases 0.000 claims 2
• KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 claims 2
• 208000004341 lymphocytic colitis Diseases 0.000 claims 2
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
• 238000011282 treatment Methods 0.000 claims 2
• NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims 2
• XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 claims 1
• GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 claims 1
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
• 208000023275 Autoimmune disease Diseases 0.000 claims 1
• 206010012735 Diarrhoea Diseases 0.000 claims 1
• 235000011054 acetic acid Nutrition 0.000 claims 1
• GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims 1
• 235000019253 formic acid Nutrition 0.000 claims 1
• 244000005709 gut microbiome Species 0.000 claims 1
• 235000019260 propionic acid Nutrition 0.000 claims 1
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 1
• 229940005605 valeric acid Drugs 0.000 claims 1
• 239000000203 mixture Substances 0.000 description 88
• 241000193403 Clostridium Species 0.000 description 25
• 241000607142 Salmonella Species 0.000 description 22
• 238000000034 method Methods 0.000 description 20
• 244000052616 bacterial pathogen Species 0.000 description 12
• 230000003115 biocidal effect Effects 0.000 description 11
• 230000001939 inductive effect Effects 0.000 description 8
• 208000015181 infectious disease Diseases 0.000 description 8
• 210000000936 intestine Anatomy 0.000 description 8
• 235000021391 short chain fatty acids Nutrition 0.000 description 7
• 208000019206 urinary tract infection Diseases 0.000 description 7
• 241000588724 Escherichia coli Species 0.000 description 6
• 241000192142 Proteobacteria Species 0.000 description 6
• 239000002246 antineoplastic agent Substances 0.000 description 6
• 108090000204 Dipeptidase 1 Proteins 0.000 description 5
• 102000002689 Toll-like receptor Human genes 0.000 description 5
• 108020000411 Toll-like receptor Proteins 0.000 description 5
• 102000006635 beta-lactamase Human genes 0.000 description 5
• 230000000694 effects Effects 0.000 description 5
• 210000003608 fece Anatomy 0.000 description 5
• 241000894006 Bacteria Species 0.000 description 4
• 241000305071 Enterobacterales Species 0.000 description 4
• 241000194033 Enterococcus Species 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
• 210000004027 cell Anatomy 0.000 description 4
• 208000037976 chronic inflammation Diseases 0.000 description 4
• 210000002429 large intestine Anatomy 0.000 description 4
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
• 241000607768 Shigella Species 0.000 description 3
• 239000003242 anti bacterial agent Substances 0.000 description 3
• 229940041181 antineoplastic drug Drugs 0.000 description 3
• 230000000112 colonic effect Effects 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 229940124597 therapeutic agent Drugs 0.000 description 3
• 241000868590 Barnesiellaceae Species 0.000 description 2
• 241000589876 Campylobacter Species 0.000 description 2
• 241000606161 Chlamydia Species 0.000 description 2
• 241000588722 Escherichia Species 0.000 description 2
• 241001646719 Escherichia coli O157:H7 Species 0.000 description 2
• 241000589989 Helicobacter Species 0.000 description 2
• 206010020608 Hypercoagulation Diseases 0.000 description 2
• 206010020751 Hypersensitivity Diseases 0.000 description 2
• 206010022489 Insulin Resistance Diseases 0.000 description 2
• 241001112693 Lachnospiraceae Species 0.000 description 2
• 241000186359 Mycobacterium Species 0.000 description 2
• 229910002651 NO3 Inorganic materials 0.000 description 2
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
• 206010035664 Pneumonia Diseases 0.000 description 2
• 241000095588 Ruminococcaceae Species 0.000 description 2
• 102000000591 Tight Junction Proteins Human genes 0.000 description 2
• 108010002321 Tight Junction Proteins Proteins 0.000 description 2
• 108010059993 Vancomycin Proteins 0.000 description 2
• 241000607598 Vibrio Species 0.000 description 2
• 206010048038 Wound infection Diseases 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 230000031729 antibacterial peptide production Effects 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 2
• 230000006020 chronic inflammation Effects 0.000 description 2
• 208000037893 chronic inflammatory disorder Diseases 0.000 description 2
• 230000003013 cytotoxicity Effects 0.000 description 2
• 231100000135 cytotoxicity Toxicity 0.000 description 2
• 229950009791 durvalumab Drugs 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 238000001631 haemodialysis Methods 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 230000000322 hemodialysis Effects 0.000 description 2
• 230000003027 hypercoagulation Effects 0.000 description 2
• 244000005706 microflora Species 0.000 description 2
• 210000003097 mucus Anatomy 0.000 description 2
• 229960003301 nivolumab Drugs 0.000 description 2
• 229960002621 pembrolizumab Drugs 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 230000008439 repair process Effects 0.000 description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 description 2
• 210000000813 small intestine Anatomy 0.000 description 2
• 238000001228 spectrum Methods 0.000 description 2
• 208000011580 syndromic disease Diseases 0.000 description 2
• 230000008719 thickening Effects 0.000 description 2
• 210000001578 tight junction Anatomy 0.000 description 2
• MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
• 229960003165 vancomycin Drugs 0.000 description 2
• MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
• 241000607528 Aeromonas hydrophila Species 0.000 description 1
• 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
• 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
• 241000193830 Bacillus <bacterium> Species 0.000 description 1
• 241000193755 Bacillus cereus Species 0.000 description 1
• 241000589968 Borrelia Species 0.000 description 1
• 241000589562 Brucella Species 0.000 description 1
• 241001453380 Burkholderia Species 0.000 description 1
• 241000589874 Campylobacter fetus Species 0.000 description 1
• 241000193163 Clostridioides difficile Species 0.000 description 1
• 241000193155 Clostridium botulinum Species 0.000 description 1
• 241000588921 Enterobacteriaceae Species 0.000 description 1
• 241000589601 Francisella Species 0.000 description 1
• 241000606790 Haemophilus Species 0.000 description 1
• 241000588748 Klebsiella Species 0.000 description 1
• 241000589248 Legionella Species 0.000 description 1
• 208000007764 Legionnaires' Disease Diseases 0.000 description 1
• 241001503405 Leptosira Species 0.000 description 1
• 241000186781 Listeria Species 0.000 description 1
• 241000186779 Listeria monocytogenes Species 0.000 description 1
• 206010067125 Liver injury Diseases 0.000 description 1
• 208000016604 Lyme disease Diseases 0.000 description 1
• 201000009906 Meningitis Diseases 0.000 description 1
• 241000588771 Morganella <proteobacterium> Species 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 241000984031 Orientia Species 0.000 description 1
• 241000607000 Plesiomonas Species 0.000 description 1
• 241000606701 Rickettsia Species 0.000 description 1
• 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
• 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
• 206010062255 Soft tissue infection Diseases 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• 208000031650 Surgical Wound Infection Diseases 0.000 description 1
• 241000607265 Vibrio vulnificus Species 0.000 description 1
• 241000607734 Yersinia <bacteria> Species 0.000 description 1
• 241000607447 Yersinia enterocolitica Species 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
• 229940125364 angiotensin receptor blocker Drugs 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 229960003852 atezolizumab Drugs 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 210000004534 cecum Anatomy 0.000 description 1
• 208000020832 chronic kidney disease Diseases 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 229940124307 fluoroquinolone Drugs 0.000 description 1
• 231100000753 hepatic injury Toxicity 0.000 description 1
• 238000001794 hormone therapy Methods 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 229960005386 ipilimumab Drugs 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 208000030159 metabolic disease Diseases 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 206010040872 skin infection Diseases 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 229940066453 tecentriq Drugs 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• 229940098232 yersinia enterocolitica Drugs 0.000 description 1
• 229940055760 yervoy Drugs 0.000 description 1
• 150000003952 β-lactams Chemical class 0.000 description 1